106 related articles for article (PubMed ID: 198298)
21. Inactivated-concentrated virus antigen for indirect complement fixation test of foot-and-mouth disease.
Sakaki K; Suphavilai P; Chandarkeo T
Natl Inst Anim Health Q (Tokyo); 1978; 18(3-4):128-34. PubMed ID: 216926
[TBL] [Abstract][Full Text] [Related]
22. [Determination of the efficiency of foot-and-mouth disease vaccines by the 3-point test in mice].
Bernhardt D; Runge W; Kindt H
Zentralbl Veterinarmed B; 1977; 24(4):293-6. PubMed ID: 195422
[No Abstract] [Full Text] [Related]
23. Immunology of foot-and-mouth disease in swine: experimental inactivated-virus vaccines.
Bachrach HL; McKercher PD
J Am Vet Med Assoc; 1972 Feb; 160(4):521-6. PubMed ID: 4337840
[No Abstract] [Full Text] [Related]
24. [Binary ethyleneimine as an inactivator of the foot-and-mouth disease virus].
Tekerlekov P; Veleva E
Vet Med Nauki; 1985; 22(3):3-8. PubMed ID: 2986348
[TBL] [Abstract][Full Text] [Related]
25. [Antigenic properties of some strains of foot-and-mouth disease virus].
Bazadze TsV
Veterinariia; 1971 Aug; 9():34-5. PubMed ID: 4334672
[No Abstract] [Full Text] [Related]
26. [Comparatve serological and immunological study of strains of foot-and-mouth disease virus type "O" isolated in Europe between 1963 and 1966].
Moosbrugger GA; Leunen J; Mackowiak C; Fontaine J; Roumiantzeff M
Bull Off Int Epizoot; 1967; 67(5):711-29. PubMed ID: 4303616
[No Abstract] [Full Text] [Related]
27. [Possibilities and limits of immunochemical methods (radio- and enzyme immunoassay) in testing foot-and-mouth disease vaccine].
Schilow WF; Reimann I
Arch Exp Veterinarmed; 1984 Sep; 38(5):697-703. PubMed ID: 6099107
[No Abstract] [Full Text] [Related]
28. [The effectiveness of foot-and-mouth disease vaccines in Switzerland. I. Screening tests and herd immunity].
Müller HK; Villinger F; Griot C; Ackermann M; Bruckner L; Kihm U
Schweiz Arch Tierheilkd; 1989; 131(7):379-86. PubMed ID: 2552579
[TBL] [Abstract][Full Text] [Related]
29. [Immunological aspects of foot-and-mouth disease virus (author's transl)].
Pinto AA
Arq Inst Biol (Sao Paulo); 1973; 40(3):181-95. PubMed ID: 4377405
[No Abstract] [Full Text] [Related]
30. [A system of stepwise control of foot-and-mouth disease vaccine production].
Felfe P; Dahms M; Wazel W; Lodders R; Helbig L
Arch Exp Veterinarmed; 1987 Nov; 41(6):802-5. PubMed ID: 2831827
[No Abstract] [Full Text] [Related]
31. Indirect complement fixation test with foot-and-mouth disease virus antigen concentrated by polyethylene glycol precipitation.
Sakaki K; Suphavilai P; Kongthon S
Natl Inst Anim Health Q (Tokyo); 1978; 18(1):8-17. PubMed ID: 206842
[TBL] [Abstract][Full Text] [Related]
32. A simple quantitative microtest for determination of the complement fixing activity of foot-and-mouth disease virus.
Petr G; Láznicka F
Acta Virol; 1972 Mar; 16(2):133-40. PubMed ID: 4401070
[No Abstract] [Full Text] [Related]
33. [Immune ascites fluids for typing the foot-and-mouth disease virus].
Ravilov AZ; Shafikova RA; Sharafutdinova KN
Veterinariia; 1972 Jan; 1():33-4. PubMed ID: 4353657
[No Abstract] [Full Text] [Related]
34. The use of BHK suspension cells for the commercial production of foot and mouth disease vaccines over a twenty year period.
Radlett PJ; Pay TW; Garland AJ
Dev Biol Stand; 1985; 60():163-70. PubMed ID: 2995169
[TBL] [Abstract][Full Text] [Related]
35. Detection of virus infection-associated antigen and 3D antibodies in cattle vaccinated against foot and mouth disease.
O'Donnell VK; Smitsaart E; Cetra B; Duffy S; Finelli J; Boyle D; Draghi G; Fondevila N; Schudel AA
Rev Sci Tech; 1997 Dec; 16(3):833-40. PubMed ID: 9567309
[TBL] [Abstract][Full Text] [Related]
36. [Antigenic properties of the foot-and-mouth disease virus concentrated by polyethylene glycol].
Sobko AI; Prokhorov VN; Sokolov LN; Koshetsian EG
Veterinariia; 1973 May; 49(5):67-8. PubMed ID: 4353691
[No Abstract] [Full Text] [Related]
37. [Safety of foot-and-mouth disease vaccines in cell cultures].
Tekerlekov P; Dilovski M; Gergov P; Nikolova E
Vet Med Nauki; 1982; 19(1):21-5. PubMed ID: 6287707
[TBL] [Abstract][Full Text] [Related]
38. [Quantitative studies of the complement fixation technique after Wadsworth, Maltaner & Maltaner in the foot-and-mouth disease. I. Preparation of antigens. Optimal condition of fixation. Isofixation curves (author's transl)].
Pinto AA; Netto CF
Arq Inst Biol (Sao Paulo); 1973; 40(3):233-42. PubMed ID: 4377406
[No Abstract] [Full Text] [Related]
39. [Anti-foot-and-mouth vaccines combined with other bacterial or viral vaccines].
Favre H; Valette L; Précausta P; Roulet C; Brun A; Terré J; Fontaine J; Stellmann C
Dev Biol Stand; 1976; 35():409-28. PubMed ID: 198309
[TBL] [Abstract][Full Text] [Related]
40. [Changes in antigen properties of foot-and-mouth disease virus during several passages].
Salajov EL; Avilov VS; Revenkov AG
Bull Off Int Epizoot; 1972; 77(5):935-40. PubMed ID: 4350009
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
